Vargas AC, Uclés VV, Argüelles AAB, González CJP

Idioma: Español
Referencias bibliográficas: 22
Paginas: 32-38
Archivo PDF: 648.94 Kb.

RESUMEN

El número de pacientes con síndrome de fatiga relacionado con cáncer ha aumentado en la última década debido a la mayor sobrevida de pacientes oncológicos. La fatiga es un síntoma serio en pacientes con cáncer que puede afectar profundamente la calidad de vida y, como muchos factores pueden contribuir a este síntoma, su manejo es un desafío que requiere de una valoración integral y prioritaria. Sin embargo, este síndrome es subdiagnosticado y subtratado por la existencia de barreras importantes por parte del paciente así como del clínico tratante para identificarlo. El tratamiento incluye tanto medidas farmacológicas como no farmacológicas.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Neefejes E van der Vorst M Blauwhoff- Buskermoles S Verheul H. Aiming for a Better Understanding and Management of Cancer- Related Fatigue. The Oncologist. 2013; 18:1135-1143.

2. Berger A Mooney K Alvarez-Pérez A et al. NCCN Clinical Practice Guidelines in Oncology. Cáncer- Related Fatigue versión 2.2015. 2015. Disponible en: http://www.nccn.org.

3. Shun S Lai Y Hsiao F. Patient-related barriers to fatigue communication in cancer patients receiving active treatment. The Oncologist. 2009;14:936-943.

4. Donovan K McGinty H Jacobsen P. A systematic review of research using the diagnostic criteria for cancer-related fatigue. Psychooncology. 2013;22:737-744.

5. Bower J Lamkin D. Inflammation and cancer- related fatigue: Mechanisms, contributing factors, and treatment implications. Brain Behav Immun. 2013;30(0):1-20.

6. Barsevick A Frost M Zwinderman A Hall P Halyard M. I’m so tired: biological and genetic mechanisms of cancer-related fatigue. Qual life Res. 2010;19:1419-1427.

7. Khamoui A Kim J. Candidate mechanisms underlying effects of contractile activity on muscle morphology and energetics in cancer cachexia. Eur J Cancer Care. 2012;21:143- 157.

8. Hofman M Ryan J Figueroa-Moseley C Jean-Pierre P Morrow G. Cancer-Related Fatigue: the scale of the problema. The Oncologist. 2007;12(suppl 1):4-10.

9. Servaes P Gielissen M Verhagen S Bleijenberg G. The course of severe fatigue in disease- free breast cancer patients: A longitudinal study. Psychooncology. 2006;16:787– 795.

10. Bower E. Screening, assessment and management of fatigue in adult survivors of cancer: an American Society of Clinical Oncology Clinical Practice Guideline. American Society of Clinical oncology. 2014.

11. Murphy H Alexander S Stone P. Investigation of diagnostic criteria for cancer-related fatigue syndrome in patients with advanced cancer: a feasibility study. Palliat Med. 2006;20:413-418.

12. Cella D Davis K Breitbart W Curt G. Cancer- Related Fatigue: Prevalence of Proposed Diagnostic Criteria in a United States Sample of Cancer Survivors. J Clin Oncol. 2001;19:3385-3395.

13. Kangas M Bovbjerg D Montgomery G. Cancer-Related Fatigue: A Systematic and Meta-Analytic Review of Non- Pharmacological Therapies for Cancer Patients. Psychol Bull. 2008; 134:700–741.

14. Seruga B Zhang H Bernstein L Tannock I. Cytokines and their relationship to the symptoms and outcome of cancer. Nat Rev Cancer. 2008

15. Wyrick K Davis A. Cochrane for Clinicians. Exercise for the Management of Cancer- Related Fatigue. Am Fam Physician. 2009; 80:689-690.

16. Luctkar-Flude M Groll D Woodend K Tranmer J. Fatigue and Physical Activity in Older Patients With Cancer: A Six-Month Follow-Up Study. Oncol Nurs Forum. 2009;36:194-202.

17. Minton O Richardson A Sharpe M Hotopf M Stone P. Drug therapy for the management of cancer-related fatigue (Review). The Cochrane Library. 2013.

18. Gong S Sheng P Jin H et al. Effect of Methylphenidate in Patients with Cancer- Related Fatigue: A Systematic Review and Meta-Analysis. Plos one. 2014;9:1-8.

19. Aapro M Jekmann W Constantinescu S Leyland-Jones. Effects of erythropoietin receptors and erythropoiesis-stimulating agents on disease progression in cancer. Br J Cancer. 2012; 106:1249-1258.

20. Kim J Yong Park C Lee S. Effects of Sun Ginseng on subjective quality of life in cancer patients: a double-blind, placebocontrolled pilot trial. J Clin Pharm Ther. 2006; 31:331-334.

21. Jia L Zhao Y. Current Evaluation of the Millennium Phytomedicine- Ginseng (I): Etymology, Pharmacognosy, Phytochemistry, Market and Regulations. Curr Med Chem. 2009;16:2475-2484.

22. Paschoi M Riechelmann R Conceicao L Hassan B Branco F Del Giglio A. Guarana (Paullinia cupana) Improves Fatigue in Breast Cancer Patients Undergoing Systemic Chemotherapy. Altern Complement Med. 2011;6:505-512.